September 4, 2026
Onco-Innovations Advances ONC010 Toward Clinical Trials with Key Manufacturing Milestones
September 4, 2026
VERAXA Biotech Appoints Veteran Finance Executive Raju Willener as CFO to Drive Capital Strategy and Oncology Pipeline Growth
September 3, 2026
OS Therapies to Present at Moody Capital Conference Amid Key Regulatory Milestones for OST-HER2
September 3, 2026
Immunotherapy Before Surgery May Improve Glioblastoma Outcomes, Preclinical Study Finds
September 2, 2026
Protecting the Thymus During Lung Cancer Treatment Could Improve Outcomes, Study Finds
September 1, 2026
Harrisburg Hematologist Dr. Salman Fazal Earns Third Consecutive Castle Connolly Top Doctor Honor
August 31, 2026
NanoViricides Advances NV-387 Measles Treatment Toward Phase II Trial Amid Rising Cases
August 31, 2026
TransCode Therapeutics Reports Survival Benefit in Preclinical Breast Cancer Bone Metastasis Study
August 30, 2026
Nurse’s Metastatic Breast Cancer Journey Highlights Importance of New Treatment Options
August 26, 2026
Heidelberg Pharma and Huadong Medicine Secure NMPA Approval for HDP-101 Combination Trial in China
August 25, 2026
Novogenia Launches Expanded MGT Plus Methylation Test in the U.S., Broadening Its International Product Portfolio
August 25, 2026
Citius Pharmaceuticals Leverages FDA-Approved LYMPHIR and Late-Stage Pipeline to Drive Growth
August 25, 2026
Marietta Prosthodontist Dr. David Zelby Recognized as 2026 Castle Connolly Top Dentist
August 24, 2026
VERAXA and Secarna Report Positive Early Data in Antibody-Oligonucleotide Collaboration
August 24, 2026
VERAXA Biotech Advances VXA-222 Cancer Program Beyond Discovery Phase, Strengthens IP Portfolio
August 20, 2026
Study Finds Most Young Adults Already Show Signs of Cardiovascular-Kidney-Metabolic Syndrome
August 19, 2026
Quantum BioPharma’s Lucid-MS Targets Myelin Protection as New Approach to MS Treatment
August 19, 2026
Quantum BioPharma’s Lucid-MS Advances Toward Phase 2 Trials as MS Treatment Focus Expands Beyond Inflammation
August 17, 2026
Helix BioPharma Appoints Dr. Markus Loeffler as Chief Medical Officer to Drive Next Phase of Oncology Clinical Development
August 17, 2026
Cayenne Wellness Center to Host 5th Annual Hispanic Heritage Month Educational Summit on Sickle Cell Disease
August 15, 2026
Memoir Chronicles a Mother’s Decades-Long Fight to Reunite with Abducted Daughter Across Three Continents
August 14, 2026
Onco-Innovations Advances ONC010 Toward First-in-Human Trials with Key Manufacturing and Metabolic Studies
August 13, 2026
NeOnc’s NEO100 Shows Strong Survival Signal in Phase 2a, Paving Way for Regulatory Discussions
August 10, 2026
NanoViricides Gets Approval for Phase II Ebola Trial in DRC, Offering Oral Treatment Option
August 10, 2026
Telomir Pharmaceuticals Publishes Peer-Reviewed Data Supporting Telomir-Zn for Triple-Negative Breast Cancer
August 7, 2026
Quantum BioPharma’s Dual Strategy Targets Neurological Health with MS Drug and Alcohol Supplement
August 7, 2026
Spanish Case of Pork Tapeworm Mimicking Brain Cancer Underscores Diagnostic Challenges and Need for New Treatments
August 6, 2026
Keep A Breast Foundation Unveils 2026 High Desert Collection to Spark Conversations on Breast Health
